View of Clinical Evaluation of a Time-Sequential Biphasic NMN–Resveratrol–Quercetin–Piperine NAD+ Supplement Targeting SIRT1 (BCLC™)

Return to Article Details Clinical Evaluation of a Time-Sequential Biphasic NMN–Resveratrol–Quercetin–Piperine NAD+ Supplement Targeting SIRT1 (BCLC™) Download Download PDF